Evidence map›Paper›PMID 37713087›Full record

ArticleAngewandte Chemie (International ed. in English)2023

Site-Specific m

Ying Xu, Yufan Wang, Fu-Sen Liang

Open access · bronzeAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. The Role of NMedComm · 2026
    Review
  2. Programmable RNA NAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Targeting RNA adenosine editing and modification enzymes for RNA therapeutics.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ying XuDepartment of Chemistry, Case Western Reserve University, 2080 Adelbert Rd, Cleveland, OH 44106, USA.
Yufan WangDepartment of Chemistry, Case Western Reserve University, 2080 Adelbert Rd, Cleveland, OH 44106, USA.
Fu-Sen LiangDepartment of Chemistry, Case Western Reserve University, 2080 Adelbert Rd, Cleveland, OH 44106, USA.ORCID 0000-0002-1793-0824
Case Western Reserve University · US

Funding

Spatiotemporal Epitranscriptome Editing TechnologyR21CA247638 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI LIANG, FU-SEN · 2020 to 2020
$602k
NCI NIH HHS R21 CA247638NIH HHS R21CA247638
6 · The paper itself

Abstract

N6-methyladenosine (m

Indexed as

AdenosineCRISPR-Cas SystemsGene EditingHumansAdenosineN-methyladenosineCas13bm6AProtein DegradationRNAShield-1

Identifiers

PMID37713087
PMCPMC10592254
OpenAlexW4385239376

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.